---

Currently, the treatments used for this disease are not accessible to all sectors of the population due to their high costs and scope, since a treatment can reach up to $500,000 per year if detected at an advanced stage. On the other hand, it is known that people most prone to this disease are people of low resources and/or who live in places where access to these treatments is difficult due to distances, in addition to these people are engaged in agricultural work, livestock and other activities where they are constantly exposed to the sun and other risk factors for prolonged periods.

---